EnGeneIC Cancer Research Foundation
A new dawn in the fight against cancer
Save the Date
The EnGeneIC Cancer Research Foundation (ECRF) is pleased to announce that after 6 years of hibernation due to the high risk of Covid-19 and Influenza infections, we are re-energized and re-igniting our legendary GALA black tie dinners.
On Friday the 13th of March 2026, we are delighted to be hosting a black tie “Celestial Ball” to celebrate the cosmic nature of the work we do.
Our Foundation supports patients into clinical trials and provides scholarships to scientists and clinicians for post-graduate translational research in low survival cancers.
ECRF Car Raffle
Congratulations to the lucky winner of the MG ZS Excite, Deidre Bethwaite!
Deidre is pictured here celebrating the win with Drs Himanshu Brahmbhatt and Jennifer MacDiarmid.
The ECRF Vision
The EnGeneIC Cancer Research Foundation (ECRF) is committed to challenging exisiting approaches to treating cancer and to encouraging the development of therapies that are tailored to the individual and not simply standardised across patients.
How To Help
Every dollar you donate is spent wholly and solely on cancer patients and cancer research.
Who We Are
The ECRF was founded in 2007 by Dr. Jennifer MacDiarmid and Dr. Himanshu Brahmbhatt, two acclaimed and dedicated scientists, who are on a quest to develop a cancer cure.
What We Do
We proudly support innovative, creative, novel cancer therapies and transitional oncology research that are key to making a difference in how cancer is treated.
Australian Story - For the Holy Grail
Watch the story that started it all
Dr Jennifer MacDiarmid and Dr Himanshu Brahmbhatt were working on a disease in sheep at the CSIRO in the early 1990s when one of their colleagues was diagnosed with lung cancer. The day before he died, the colleague urged them to start working on a cure for cancer.
Read More
They began researching that very night, and initially focused on plant extracts which might have an effect on cancer cells.
A few years later, their boss at the CSIRO, Sir Malcolm McIntosh announced that he had terminal kidney cancer. They began treating him with the plant extracts, and were so encouraged by the results, they decided to leave the CSIRO to set up their own company. Eventually they developed a new idea to deliver anti-cancer drugs to the body in a way that avoids the need for intravenous chemotherapy.
The technique targets the cancer with a nano-cell called an ‘EDV’ or EnGeneIC Dream Vector and releases drugs directly into cancer cells, avoiding the side affects associated with conventional chemotherapy.
Get in Touch. Get Involved.
PO Box 1643, Lane Cove, NSW 1595
ACN: 127 831 154 ABN 24 756 847 193
info@engeneicfoundation.org.au
EnGeneIC Cancer Research Foundation is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity: Charitable Fundraising Authority No 24486
